James H. Sabry, Director at CYTOKINETICS INC (CYTK), sold 48,800 shares at $3.43 ($168K) on 2009-11-17, disclosed to the SEC on 2009-11-18.
Open-market sale of $168k CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.42 | 1,000 | $3K | 2.0% |
| 2 | $3.43 | 8,875 | $30K | 18.1% |
| 3 | $3.44 | 17,151 | $59K | 35.1% |
| 4 | $3.45 | 13,964 | $48K | 28.7% |
| 5 | $3.46 | 5,610 | $19K | 11.5% |
| 6 | $3.47 | 1,700 |
| $6K |
| 3.5% |
| 7 | $3.50 | 500 | $2K | 1.0% |
| Total | $3.44 avg | 48,800 | $168K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |